Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Fortune

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|April 28, 2016
Ocular presentation of natural killer/T-cell lymphoma in a Caucasian manEmily Hughes, Helen Fogarty, Anne Fortune, et al.
Case Reports in Hematology|January 30, 2018
Late Emergence of an Imatinib-Resistant <i>ABL1</i> Kinase Domain Mutation in a Patient with Chronic Myeloid LeukemiaMireille Crampe, Claire Andrews, Anne Fortune, et al.
Clinical Laboratory|February 5, 2015
Splenectomy-related red cell lysis resistance causing analytical difficulty in a patient with a hematological malignancyBarry Kevane, Anna Dowd, Aine Lennon, et al.
Emerging Infectious Diseases|June 23, 2021
Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, IrelandMaureen Lynch, Guerrino Macori, Séamus Fanning, et al.
Leukemia & Lymphoma|May 7, 2010
T-lymphoblastic leukemia/lymphoma: a single center retrospective study of outcomeAnne Fortune, Hilary O'Leary, Ruth Gilmore, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasmsSarah Kelliher, Sara Gamba, Luisa Weiss, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 21, 2021
Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive DisorderLaura McDonald, Roseann O' Doherty, Eileen Ryan, et al.
Expert Opinion on Investigational Drugs|April 23, 2026
Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myelomaYuxin Liu, Clifton Mo, Shonali Midha, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|April 28, 2016
Ocular presentation of natural killer/T-cell lymphoma in a Caucasian manEmily Hughes, Helen Fogarty, Anne Fortune, et al.
Case Reports in Hematology|January 30, 2018
Late Emergence of an Imatinib-Resistant <i>ABL1</i> Kinase Domain Mutation in a Patient with Chronic Myeloid LeukemiaMireille Crampe, Claire Andrews, Anne Fortune, et al.
Clinical Laboratory|February 5, 2015
Splenectomy-related red cell lysis resistance causing analytical difficulty in a patient with a hematological malignancyBarry Kevane, Anna Dowd, Aine Lennon, et al.
Emerging Infectious Diseases|June 23, 2021
Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, IrelandMaureen Lynch, Guerrino Macori, Séamus Fanning, et al.
Leukemia & Lymphoma|May 7, 2010
T-lymphoblastic leukemia/lymphoma: a single center retrospective study of outcomeAnne Fortune, Hilary O'Leary, Ruth Gilmore, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasmsSarah Kelliher, Sara Gamba, Luisa Weiss, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 21, 2021
Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive DisorderLaura McDonald, Roseann O' Doherty, Eileen Ryan, et al.
Expert Opinion on Investigational Drugs|April 23, 2026
Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myelomaYuxin Liu, Clifton Mo, Shonali Midha, et al.
Pageof 1